Clinical Trial

Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India

Study acronym: HPV-Vac-S
Recruiting
View on ClinicalTrials.gov →
Summary
This project aims is to monitor the effectiveness of HPV vaccination in real-word conditions, at least 7 years after initiation of HPV vaccination in Sikkim. This study would give an opportunity to provide rapid feedback to the Indian public health authorities about the impact of the HPV vaccine.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-10-09; most recent amendment 2026-03-30.
Status change: Not Yet Recruiting → Recruiting 2021-02-16
Trial Details
NCT Number NCT04588402
Lead Sponsor International Agency for Research on Cancer
Collaborators: Department of Health and Family welfare, Government of Sikkim, Sikkim Manipal Institute, Rajiv Gandhi Centre for Biotechnology
Conditions Cervical Cancer
Enrollment 5,500 participants
Start Date 2020-10-01
Primary Completion 2026-10-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-03